Chemotherapy-Induced Anemia Market Dynamics: Drivers, Challenges, and Opportunities
Cancer patients undergoing chemotherapy frequently develop anemia as a debilitating side effect, driven primarily by bone marrow suppression and, in certain cases, kidney dysfunction linked to agents such as cisplatin. This condition, referred to as chemotherapy induced anemia, contributes to fatigue, cardiovascular complications, and a marked decline in patient quality of life, making it a...
0 Commentarii 0 Distribuiri 2K Views 0 previzualizare